• News
  • SAN DIEGO
  • BioTech

EU committee rejects Vivus weight-loss drug

A panel of advisers to the European Union's health agency has again rejected Vivus Inc.'s weight-loss drug for sale in Europe.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!